Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Luminex Corporation (NasdaqNM:LMNX)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials | Reports
Location
12212 Technology Blouvard
Austin, TX 78727
Phone: (512) 219-8020
Fax: (512) 258-4173
Email: info@luminexcorp.com
Employees (last reported count): 132
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Products & Services
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 58%
·Over the last 6 months:
 · one insider buy; 10.0K shares
 · 3 insider sells; 17.0K shares
  (0.1% of insider shares)
·Institutional: 36% (86% of float)
(123 institutions)
·Net Inst. Buying: 670.0K shares (+6.14%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Luminex Corporation manufactures and markets products incorporating a proprietary technology that advances and simplifies biological testing for the life sciences industry. This industry depends on a broad range of tests, called bioassays, to perform diagnostic tests, to discover new drugs and to identify new genes. The Company's LabMAP technology allows its Luminex 100 system to simultaneously perform up to 100 bioassays on a single drop of fluid by reading biological tests taking place on the surface of microscopic polystyrene beads called microspheres. The Company's LabMAP technology is currently being used within the various segments of the life sciences industry in the fields of drug discovery, clinical diagnostics, genetic analysis and biomedical research.
More from Market Guide: Expanded Business Description

Financial Summary
Luminex Corp. developes, manufactures, and markets a proprietary technology that simplifies biological testing for the life sciences industry. For the six months ended 6/30/01, revenues totaled $8.6 million, up from $2.8 million. Net loss increased 33% to $8.3 million. Revenues reflect increased product sales due to the rapid adoption of LabMAP technology and increased purchases by existing customers. Higher loss reflects increased development and personnel expenses.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Mark Chandler, Ph.D., 47
Chairman, Pres, CEO
$350K--  
Frank Reeves
CFO, Exec. VP, Treasurer
--  --  
Gail Page, 45
COO, Exec. VP
--  --  
Michael Bengtson, 43
Exec. VP, Gen. Counsel, Sec.
232K$169K
James Schepp
VP of Sales and Marketing
--  --  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:LMNXAs of 31-Aug-2001
Price and Volume
52-Week Low
on 17-Apr-2001
$11.95 
Recent Price$19.35 
52-Week High
on 5-Sep-2000
$41.00 
Daily Volume (3-month avg)146.5K
Daily Volume (10-day avg)99.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y]
52-Week Change-51.6%
52-Week Change
relative to S&P500
-35.1%
Share-Related Items
Market Capitalization$548.9M
Shares Outstanding28.4M
Float11.9M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$2.57 
Earnings (ttm)-$0.52 
Earnings (mrq)-$0.15 
Sales (ttm)$0.52 
Cash (mrq)$2.16 
Valuation Ratios
Price/Book (mrq)7.54 
Price/EarningsN/A 
Price/Sales (ttm)37.34 
Income Statements
Sales (ttm)$14.4M
EBITDA (ttm)-$16.7M
Income available to common (ttm)-$14.5M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-17.68%
Return on Equity (ttm)-18.51%
Financial Strength
Current Ratio (mrq)23.59 
Debt/Equity (mrq)0 
Total Cash (mrq)$61.3M
Short Interest
As of 8-Aug-2001
Shares Short2.78M
Percent of Float23.4%
Shares Short
(Prior Month)
2.75M
Short Ratio20.61 
Daily Volume135.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.